The chemotherapy infusion pumps market size has grown strongly in recent years. It will grow from $5.2 billion in 2025 to $5.51 billion in 2026 at a compound annual growth rate (CAGR) of 6%. The growth in the historic period can be attributed to rising global cancer incidence, increasing use of chemotherapy as a primary treatment, expansion of oncology treatment centers, growing adoption of infusion-based drug delivery, improvements in infusion pump safety standards.
The chemotherapy infusion pumps market size is expected to see strong growth in the next few years. It will grow to $6.95 billion in 2030 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to increasing shift toward outpatient cancer treatment, rising demand for home-based oncology care, growing focus on reducing hospital stay duration, increasing adoption of personalized chemotherapy regimens, expanding access to cancer treatment in emerging markets. Major trends in the forecast period include rising adoption of ambulatory and home-based chemotherapy delivery, increasing demand for precise and controlled drug administration, growing preference for disposable infusion pump systems, expansion of continuous chemotherapy infusion protocols, increasing focus on patient comfort and treatment adherence.
The rising incidence of cancer is expected to drive the growth of the chemotherapy infusion pumps market. Cancer is a group of diseases marked by uncontrolled cell growth and spread within the body, influenced by factors such as lifestyle changes, genetic predispositions, and environmental elements such as smoking, radiation, chemicals, and infections. Chemotherapy infusion pumps support cancer patients by providing accurate, continuous doses of chemotherapy drugs, improving drug administration, and reducing side effects. For example, in February 2024, the World Health Organization, based in Switzerland, projected over 35 million new cancer cases by 2050, up 77% from the 20 million cases estimated for 2022. This rising incidence of cancer is set to boost the demand for chemotherapy infusion pumps.
Key players in the chemotherapy infusion pumps market are developing advanced technologies, such as customizable infusion rates for multiple chemotherapy drugs, to offer more personalized and precise treatment options. Customizable infusion rates enable healthcare providers to adjust the delivery speed and dosage of chemotherapy drugs according to individual patient needs. For instance, in May 2023, Mindray, a medical device and solution provider from China, launched a new infusion mode called 'Rhythm Dose' in their BeneFusion i/u infusion pump series. This feature is designed to optimize chemotherapy drug delivery, allowing continuous intravenous infusions of multiple drugs at varying rates for more personalized treatment plans.
In November 2024, Boston Scientific Corporation, a US-based medical technology company, acquired Intera Oncology Inc. for an undisclosed amount. Through this acquisition, Boston Scientific seeks to enhance its interventional oncology portfolio by incorporating Intera Oncology’s hepatic arterial infusion pump technology and broadening access to more precise, targeted, and effective cancer treatment solutions across global healthcare markets. Intera Oncology Inc. is a US-based medical device company that specializes in implantable pump systems for the direct delivery of chemotherapy to the liver.
Major companies operating in the chemotherapy infusion pumps market are Becton Dickinson and Company, Baxter International Inc., B Braun Melsungen AG, ICU Medical Inc., Fresenius Kabi AG, Medtronic plc, Smiths Medical, Terumo Corporation, Moog Inc., Nipro Corporation, Micrel Medical Devices SA, Zyno Medical LLC, Mindray Medical International Limited, Insulet Corporation, Tandem Diabetes Care Inc., CME Medical, Eitan Medical, Codan Medizinische Geräte GmbH & Co KG, SOOIL Development Co Ltd, Q‑Core Medical Ltd.
North America was the largest region in the chemotherapy infusion pump market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chemotherapy infusion pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the chemotherapy infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the chemotherapy infusion pumps market by increasing costs for imported electronic components, sensors, batteries, and medical-grade plastics used in pump manufacturing. These cost increases have affected pricing for smart infusion pumps and ambulatory infusion systems, particularly in north america and asia-pacific regions with globalized supply chains. Higher tariffs have raised procurement costs for hospitals and home care providers and slowed replacement cycles. However, tariffs have also encouraged local manufacturing, regional sourcing, and design optimization, supporting long-term supply chain resilience.
The chemotherapy infusion pumps market research report is one of a series of new reports that provides chemotherapy infusion pumps market statistics, including chemotherapy infusion pumps industry global market size, regional shares, competitors with a chemotherapy infusion pumps market share, detailed chemotherapy infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the chemotherapy infusion pumps industry. This chemotherapy infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Chemotherapy infusion pumps are specialized medical devices used to deliver precise and continuous doses of chemotherapy drugs to cancer patients. They play a crucial role in optimizing drug administration, minimizing side effects, and enabling treatments to be administered over extended periods, whether in a hospital setting or at home.
The primary types of chemotherapy infusion pumps in the market include large volume pumps, syringe pumps, elastomeric pumps, ambulatory infusion pumps, and others. Large volume chemotherapy infusion pumps are designed to administer significant quantities of chemotherapy drugs over extended durations. These pumps can be either disposable or reusable and are utilized by various end users, including hospitals, clinics, home care settings, and other medical environments.
The chemotherapy infusion pumps market consists of sales of portable elastomeric infusion pumps, electronic infusion pumps, implantable infusion pumps, and patient-controlled analgesia (PCA) pumps. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The chemotherapy infusion pumps market size is expected to see strong growth in the next few years. It will grow to $6.95 billion in 2030 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to increasing shift toward outpatient cancer treatment, rising demand for home-based oncology care, growing focus on reducing hospital stay duration, increasing adoption of personalized chemotherapy regimens, expanding access to cancer treatment in emerging markets. Major trends in the forecast period include rising adoption of ambulatory and home-based chemotherapy delivery, increasing demand for precise and controlled drug administration, growing preference for disposable infusion pump systems, expansion of continuous chemotherapy infusion protocols, increasing focus on patient comfort and treatment adherence.
The rising incidence of cancer is expected to drive the growth of the chemotherapy infusion pumps market. Cancer is a group of diseases marked by uncontrolled cell growth and spread within the body, influenced by factors such as lifestyle changes, genetic predispositions, and environmental elements such as smoking, radiation, chemicals, and infections. Chemotherapy infusion pumps support cancer patients by providing accurate, continuous doses of chemotherapy drugs, improving drug administration, and reducing side effects. For example, in February 2024, the World Health Organization, based in Switzerland, projected over 35 million new cancer cases by 2050, up 77% from the 20 million cases estimated for 2022. This rising incidence of cancer is set to boost the demand for chemotherapy infusion pumps.
Key players in the chemotherapy infusion pumps market are developing advanced technologies, such as customizable infusion rates for multiple chemotherapy drugs, to offer more personalized and precise treatment options. Customizable infusion rates enable healthcare providers to adjust the delivery speed and dosage of chemotherapy drugs according to individual patient needs. For instance, in May 2023, Mindray, a medical device and solution provider from China, launched a new infusion mode called 'Rhythm Dose' in their BeneFusion i/u infusion pump series. This feature is designed to optimize chemotherapy drug delivery, allowing continuous intravenous infusions of multiple drugs at varying rates for more personalized treatment plans.
In November 2024, Boston Scientific Corporation, a US-based medical technology company, acquired Intera Oncology Inc. for an undisclosed amount. Through this acquisition, Boston Scientific seeks to enhance its interventional oncology portfolio by incorporating Intera Oncology’s hepatic arterial infusion pump technology and broadening access to more precise, targeted, and effective cancer treatment solutions across global healthcare markets. Intera Oncology Inc. is a US-based medical device company that specializes in implantable pump systems for the direct delivery of chemotherapy to the liver.
Major companies operating in the chemotherapy infusion pumps market are Becton Dickinson and Company, Baxter International Inc., B Braun Melsungen AG, ICU Medical Inc., Fresenius Kabi AG, Medtronic plc, Smiths Medical, Terumo Corporation, Moog Inc., Nipro Corporation, Micrel Medical Devices SA, Zyno Medical LLC, Mindray Medical International Limited, Insulet Corporation, Tandem Diabetes Care Inc., CME Medical, Eitan Medical, Codan Medizinische Geräte GmbH & Co KG, SOOIL Development Co Ltd, Q‑Core Medical Ltd.
North America was the largest region in the chemotherapy infusion pump market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chemotherapy infusion pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the chemotherapy infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the chemotherapy infusion pumps market by increasing costs for imported electronic components, sensors, batteries, and medical-grade plastics used in pump manufacturing. These cost increases have affected pricing for smart infusion pumps and ambulatory infusion systems, particularly in north america and asia-pacific regions with globalized supply chains. Higher tariffs have raised procurement costs for hospitals and home care providers and slowed replacement cycles. However, tariffs have also encouraged local manufacturing, regional sourcing, and design optimization, supporting long-term supply chain resilience.
The chemotherapy infusion pumps market research report is one of a series of new reports that provides chemotherapy infusion pumps market statistics, including chemotherapy infusion pumps industry global market size, regional shares, competitors with a chemotherapy infusion pumps market share, detailed chemotherapy infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the chemotherapy infusion pumps industry. This chemotherapy infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Chemotherapy infusion pumps are specialized medical devices used to deliver precise and continuous doses of chemotherapy drugs to cancer patients. They play a crucial role in optimizing drug administration, minimizing side effects, and enabling treatments to be administered over extended periods, whether in a hospital setting or at home.
The primary types of chemotherapy infusion pumps in the market include large volume pumps, syringe pumps, elastomeric pumps, ambulatory infusion pumps, and others. Large volume chemotherapy infusion pumps are designed to administer significant quantities of chemotherapy drugs over extended durations. These pumps can be either disposable or reusable and are utilized by various end users, including hospitals, clinics, home care settings, and other medical environments.
The chemotherapy infusion pumps market consists of sales of portable elastomeric infusion pumps, electronic infusion pumps, implantable infusion pumps, and patient-controlled analgesia (PCA) pumps. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Chemotherapy Infusion Pumps Market Characteristics
3. Chemotherapy Infusion Pumps Market Supply Chain Analysis
4. Global Chemotherapy Infusion Pumps Market Trends and Strategies
5. Chemotherapy Infusion Pumps Market Analysis of End Use Industries
7. Global Chemotherapy Infusion Pumps Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Chemotherapy Infusion Pumps Total Addressable Market (TAM) Analysis for the Market
9. Chemotherapy Infusion Pumps Market Segmentation
10. Chemotherapy Infusion Pumps Market Regional and Country Analysis
11. Asia-Pacific Chemotherapy Infusion Pumps Market
12. China Chemotherapy Infusion Pumps Market
13. India Chemotherapy Infusion Pumps Market
14. Japan Chemotherapy Infusion Pumps Market
15. Australia Chemotherapy Infusion Pumps Market
16. Indonesia Chemotherapy Infusion Pumps Market
17. South Korea Chemotherapy Infusion Pumps Market
18. Taiwan Chemotherapy Infusion Pumps Market
19. South East Asia Chemotherapy Infusion Pumps Market
20. Western Europe Chemotherapy Infusion Pumps Market
21. UK Chemotherapy Infusion Pumps Market
22. Germany Chemotherapy Infusion Pumps Market
23. France Chemotherapy Infusion Pumps Market
24. Italy Chemotherapy Infusion Pumps Market
25. Spain Chemotherapy Infusion Pumps Market
26. Eastern Europe Chemotherapy Infusion Pumps Market
27. Russia Chemotherapy Infusion Pumps Market
28. North America Chemotherapy Infusion Pumps Market
29. USA Chemotherapy Infusion Pumps Market
30. Canada Chemotherapy Infusion Pumps Market
31. South America Chemotherapy Infusion Pumps Market
32. Brazil Chemotherapy Infusion Pumps Market
33. Middle East Chemotherapy Infusion Pumps Market
34. Africa Chemotherapy Infusion Pumps Market
36. Chemotherapy Infusion Pumps Market Competitive Landscape and Company Profiles
37. Chemotherapy Infusion Pumps Market Other Major and Innovative Companies
40. Chemotherapy Infusion Pumps Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Chemotherapy Infusion Pumps Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses chemotherapy infusion pumps market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for chemotherapy infusion pumps? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The chemotherapy infusion pumps market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Large Volume Pumps; Syringe Pump; Elastomeric Pumps; Ambulatory Infusion Pumps; Other Types2) By Usage: Disposable; Reusable
3) By End User: Hospitals; Clinics; Home Care; Other End Users
Subsegments:
1) By Large Volume Pumps: Traditional Large Volume Pumps; Volumetric Infusion Pumps2) By Syringe Pump: Manual Syringe Pumps; Electronic Syringe Pumps
3) By Elastomeric Pumps: Disposable Elastomeric Pumps; Reusable Elastomeric Pumps
4) By Ambulatory Infusion Pumps: Disposable Ambulatory Infusion Pumps; Reusable Ambulatory Infusion Pumps
5) By Other Types: Smart Infusion Pumps; Patient-Controlled Analgesia (Pca) Pumps
Companies Mentioned: Becton Dickinson and Company; Baxter International Inc.; B Braun Melsungen AG; ICU Medical Inc.; Fresenius Kabi AG; Medtronic plc; Smiths Medical; Terumo Corporation; Moog Inc.; Nipro Corporation; Micrel Medical Devices SA; Zyno Medical LLC; Mindray Medical International Limited; Insulet Corporation; Tandem Diabetes Care Inc.; CME Medical; Eitan Medical; Codan Medizinische Geräte GmbH & Co KG; SOOIL Development Co Ltd; Q‑Core Medical Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Chemotherapy Infusion Pumps market report include:- Becton Dickinson and Company
- Baxter International Inc.
- B Braun Melsungen AG
- ICU Medical Inc.
- Fresenius Kabi AG
- Medtronic plc
- Smiths Medical
- Terumo Corporation
- Moog Inc.
- Nipro Corporation
- Micrel Medical Devices SA
- Zyno Medical LLC
- Mindray Medical International Limited
- Insulet Corporation
- Tandem Diabetes Care Inc.
- CME Medical
- Eitan Medical
- Codan Medizinische Geräte GmbH & Co KG
- SOOIL Development Co Ltd
- Q‑Core Medical Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.51 Billion |
| Forecasted Market Value ( USD | $ 6.95 Billion |
| Compound Annual Growth Rate | 6.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
